Toyota|$18.01 (¥2,881)+1.30%▲ (in JPY terms)
Sony|$22.63 (¥3,619)-1.36%▼ (in JPY terms)
SoftBank|$51.99 (¥8,315)-3.67%▼ (in JPY terms)
MUFG|$19.62 (¥3,137)+2.99%▲ (in JPY terms)
Keyence|$504.17 (¥80,630)+2.92%▲ (in JPY terms)
Nintendo|$46.63 (¥7,457)+0.42%▲ (in JPY terms)
NTT|$0.92 (¥148)-0.07%▼ (in JPY terms)
Takeda|$29.69 (¥4,748)-2.10%▼ (in JPY terms)
Tokyo Electron|$380.80 (¥60,900)+13.39%▲ (in JPY terms)
Recruit|$68.28 (¥10,920)+0.69%▲ (in JPY terms)
ITOCHU|$11.62 (¥1,859)+0.05%▲ (in JPY terms)
Honda|$9.36 (¥1,497)+7.89%▲ (in JPY terms)
Shin-Etsu|$48.81 (¥7,806)+4.46%▲ (in JPY terms)
Tokio Marine|$44.38 (¥7,098)+0.74%▲ (in JPY terms)
Fast Retailing|$490.35 (¥78,420)-1.58%▼ (in JPY terms)
Toyota|$18.01 (¥2,881)+1.30%▲ (in JPY terms)
Sony|$22.63 (¥3,619)-1.36%▼ (in JPY terms)
SoftBank|$51.99 (¥8,315)-3.67%▼ (in JPY terms)
MUFG|$19.62 (¥3,137)+2.99%▲ (in JPY terms)
Keyence|$504.17 (¥80,630)+2.92%▲ (in JPY terms)
Nintendo|$46.63 (¥7,457)+0.42%▲ (in JPY terms)
NTT|$0.92 (¥148)-0.07%▼ (in JPY terms)
Takeda|$29.69 (¥4,748)-2.10%▼ (in JPY terms)
Tokyo Electron|$380.80 (¥60,900)+13.39%▲ (in JPY terms)
Recruit|$68.28 (¥10,920)+0.69%▲ (in JPY terms)
ITOCHU|$11.62 (¥1,859)+0.05%▲ (in JPY terms)
Honda|$9.36 (¥1,497)+7.89%▲ (in JPY terms)
Shin-Etsu|$48.81 (¥7,806)+4.46%▲ (in JPY terms)
Tokio Marine|$44.38 (¥7,098)+0.74%▲ (in JPY terms)
Fast Retailing|$490.35 (¥78,420)-1.58%▼ (in JPY terms)

2026-05-07 Kyowa Kirin Co.,Ltd. “Plans for the integration and relocation of research centers to further strengthen drug discovery capabilities (663KB).”

2026-05-07 Kyowa Kirin Co.,Ltd. “Plans for the integration and relocation of research centers to further strengthen drug discovery capabilities (663KB).”

AI-Generated Summary

Kyowa Kirin is consolidating its research operations through integration and relocation of research centers, which should improve operational efficiency and accelerate its drug discovery pipeline. This strategic restructuring signals management’s commitment to enhancing R&D productivity, potentially positioning the company to bring new medicines to market more quickly and cost-effectively.

This summary is AI-generated based on the release title and may not reflect the full content of the original document.

コメントする